Cargando…
Assessment of aberrant DNA methylation two years after paediatric critical illness: a pre-planned secondary analysis of the international PEPaNIC trial
Critically ill children requiring intensive care suffer from impaired physical/neurocognitive development 2 y later, partially preventable by omitting early use of parenteral nutrition (early-PN) in the paediatric intensive-care-unit (PICU). Altered methylation of DNA from peripheral blood during PI...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980627/ https://www.ncbi.nlm.nih.gov/pubmed/36384393 http://dx.doi.org/10.1080/15592294.2022.2146966 |
_version_ | 1784899936487211008 |
---|---|
author | Coppens, Grégoire Vanhorebeek, Ilse Verlinden, Ines Derese, Inge Wouters, Pieter J Joosten, Koen F. Verbruggen, Sascha C. Güiza, Fabian Van den Berghe, Greet |
author_facet | Coppens, Grégoire Vanhorebeek, Ilse Verlinden, Ines Derese, Inge Wouters, Pieter J Joosten, Koen F. Verbruggen, Sascha C. Güiza, Fabian Van den Berghe, Greet |
author_sort | Coppens, Grégoire |
collection | PubMed |
description | Critically ill children requiring intensive care suffer from impaired physical/neurocognitive development 2 y later, partially preventable by omitting early use of parenteral nutrition (early-PN) in the paediatric intensive-care-unit (PICU). Altered methylation of DNA from peripheral blood during PICU-stay provided a molecular basis hereof. Whether DNA-methylation of former PICU patients, assessed 2 y after critical illness, is different from that of healthy children remained unknown. In a pre-planned secondary analysis of the PEPaNIC-RCT (clinicaltrials.gov-NCT01536275) 2-year follow-up, we assessed buccal-mucosal DNA-methylation (Infinium-HumanMethylation-EPIC-BeadChip) of former PICU-patients (N = 406 early-PN; N = 414 late-PN) and matched healthy children (N = 392). CpG-sites differentially methylated between groups were identified with multivariable linear regression and differentially methylated DNA-regions via clustering of differentially methylated CpG-sites using kernel-estimates. Analyses were adjusted for technical variation and baseline risk factors, and corrected for multiple testing (false-discovery-rate <0.05). Differentially methylated genes were functionally annotated (KEGG-pathway database), and allocated to three classes depending on involvement in physical/neurocognitive development, critical illness and intensive medical care, or pre-PICU-admission disorders. As compared with matched healthy children, former PICU-patients showed significantly different DNA-methylation at 4047 CpG-sites (2186 genes) and 494 DNA-regions (468 genes), with most CpG-sites being hypomethylated (90.3%) and with an average absolute 2% effect-size, irrespective of timing of PN initiation. Of the differentially methylated KEGG-pathways, 41.2% were related to physical/neurocognitive development, 32.8% to critical illness and intensive medical care and 26.0% to pre-PICU-admission disorders. Two years after critical illness in children, buccal-mucosal DNA showed abnormal methylation of CpG-sites and DNA-regions located in pathways known to be important for physical/neurocognitive development. |
format | Online Article Text |
id | pubmed-9980627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-99806272023-03-03 Assessment of aberrant DNA methylation two years after paediatric critical illness: a pre-planned secondary analysis of the international PEPaNIC trial Coppens, Grégoire Vanhorebeek, Ilse Verlinden, Ines Derese, Inge Wouters, Pieter J Joosten, Koen F. Verbruggen, Sascha C. Güiza, Fabian Van den Berghe, Greet Epigenetics Research Paper Critically ill children requiring intensive care suffer from impaired physical/neurocognitive development 2 y later, partially preventable by omitting early use of parenteral nutrition (early-PN) in the paediatric intensive-care-unit (PICU). Altered methylation of DNA from peripheral blood during PICU-stay provided a molecular basis hereof. Whether DNA-methylation of former PICU patients, assessed 2 y after critical illness, is different from that of healthy children remained unknown. In a pre-planned secondary analysis of the PEPaNIC-RCT (clinicaltrials.gov-NCT01536275) 2-year follow-up, we assessed buccal-mucosal DNA-methylation (Infinium-HumanMethylation-EPIC-BeadChip) of former PICU-patients (N = 406 early-PN; N = 414 late-PN) and matched healthy children (N = 392). CpG-sites differentially methylated between groups were identified with multivariable linear regression and differentially methylated DNA-regions via clustering of differentially methylated CpG-sites using kernel-estimates. Analyses were adjusted for technical variation and baseline risk factors, and corrected for multiple testing (false-discovery-rate <0.05). Differentially methylated genes were functionally annotated (KEGG-pathway database), and allocated to three classes depending on involvement in physical/neurocognitive development, critical illness and intensive medical care, or pre-PICU-admission disorders. As compared with matched healthy children, former PICU-patients showed significantly different DNA-methylation at 4047 CpG-sites (2186 genes) and 494 DNA-regions (468 genes), with most CpG-sites being hypomethylated (90.3%) and with an average absolute 2% effect-size, irrespective of timing of PN initiation. Of the differentially methylated KEGG-pathways, 41.2% were related to physical/neurocognitive development, 32.8% to critical illness and intensive medical care and 26.0% to pre-PICU-admission disorders. Two years after critical illness in children, buccal-mucosal DNA showed abnormal methylation of CpG-sites and DNA-regions located in pathways known to be important for physical/neurocognitive development. Taylor & Francis 2022-11-16 /pmc/articles/PMC9980627/ /pubmed/36384393 http://dx.doi.org/10.1080/15592294.2022.2146966 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Coppens, Grégoire Vanhorebeek, Ilse Verlinden, Ines Derese, Inge Wouters, Pieter J Joosten, Koen F. Verbruggen, Sascha C. Güiza, Fabian Van den Berghe, Greet Assessment of aberrant DNA methylation two years after paediatric critical illness: a pre-planned secondary analysis of the international PEPaNIC trial |
title | Assessment of aberrant DNA methylation two years after paediatric critical illness: a pre-planned secondary analysis of the international PEPaNIC trial |
title_full | Assessment of aberrant DNA methylation two years after paediatric critical illness: a pre-planned secondary analysis of the international PEPaNIC trial |
title_fullStr | Assessment of aberrant DNA methylation two years after paediatric critical illness: a pre-planned secondary analysis of the international PEPaNIC trial |
title_full_unstemmed | Assessment of aberrant DNA methylation two years after paediatric critical illness: a pre-planned secondary analysis of the international PEPaNIC trial |
title_short | Assessment of aberrant DNA methylation two years after paediatric critical illness: a pre-planned secondary analysis of the international PEPaNIC trial |
title_sort | assessment of aberrant dna methylation two years after paediatric critical illness: a pre-planned secondary analysis of the international pepanic trial |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980627/ https://www.ncbi.nlm.nih.gov/pubmed/36384393 http://dx.doi.org/10.1080/15592294.2022.2146966 |
work_keys_str_mv | AT coppensgregoire assessmentofaberrantdnamethylationtwoyearsafterpaediatriccriticalillnessapreplannedsecondaryanalysisoftheinternationalpepanictrial AT vanhorebeekilse assessmentofaberrantdnamethylationtwoyearsafterpaediatriccriticalillnessapreplannedsecondaryanalysisoftheinternationalpepanictrial AT verlindenines assessmentofaberrantdnamethylationtwoyearsafterpaediatriccriticalillnessapreplannedsecondaryanalysisoftheinternationalpepanictrial AT dereseinge assessmentofaberrantdnamethylationtwoyearsafterpaediatriccriticalillnessapreplannedsecondaryanalysisoftheinternationalpepanictrial AT wouterspieterj assessmentofaberrantdnamethylationtwoyearsafterpaediatriccriticalillnessapreplannedsecondaryanalysisoftheinternationalpepanictrial AT joostenkoenf assessmentofaberrantdnamethylationtwoyearsafterpaediatriccriticalillnessapreplannedsecondaryanalysisoftheinternationalpepanictrial AT verbruggensaschac assessmentofaberrantdnamethylationtwoyearsafterpaediatriccriticalillnessapreplannedsecondaryanalysisoftheinternationalpepanictrial AT guizafabian assessmentofaberrantdnamethylationtwoyearsafterpaediatriccriticalillnessapreplannedsecondaryanalysisoftheinternationalpepanictrial AT vandenberghegreet assessmentofaberrantdnamethylationtwoyearsafterpaediatriccriticalillnessapreplannedsecondaryanalysisoftheinternationalpepanictrial |